| Mary Bryant, LPE | |
|
1217 Stone St, Jonesboro, AR 72401-4520 | |
| (870) 972-1268 | |
| Not Available |
| Full Name | Mary Bryant |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical Child & Adolescent |
| Location | 1217 Stone St, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124440888 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC2200X | Psychologist - Clinical Child & Adolescent | 13-23E (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Bryant, LPE 1217 Stone St, Jonesboro, AR 72401-4520 Ph: (870) 972-1268 | Mary Bryant, LPE 1217 Stone St, Jonesboro, AR 72401-4520 Ph: (870) 972-1268 |
News Archive
Media outlets from Connecticut, Texas and Iowa report on how a Supreme Court brief, which was filed by the Progressive States Network and signed by hundreds of state officials, is shaking up some state-level policy discussions.
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
Dr. Barry Reiner announced that he is now recruiting children and adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.
The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.
› Verified 6 days ago
Mr. David A Shade, M.S., LPE-I Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1815 Pleasant Grove Rd, Jonesboro, AR 72401 Phone: 870-933-6886 Fax: 870-933-9395 | |
Dr. Marilyn L Porter, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2707 Browns Lane, Jonesboro, AR 72401 Phone: 870-972-4939 Fax: 870-972-4911 | |
M Elizabeth Huffstutter, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1900 Stillwater Dr, Jonesboro, AR 72404 Phone: 870-932-3600 Fax: 870-932-3611 | |
Dr. Meagan Medley, LP, NCSP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3420 Western Gales Dr, Jonesboro, AR 72405 Phone: 504-812-6665 | |
Olimpia Rosario, MD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1815 Pleasant Grove Rd., Jonesboro, AR 72404 Phone: 870-933-6886 | |
Margaret B Rector, PH.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4939 Fax: 870-972-4911 |